Accenture (ACN) Proxy Filing summary

Executive summary

• Annual general meeting scheduled for February 6, 2025, in Dublin, Ireland, with key proposals including director appointments, executive compensation, auditor ratification, and several Irish law matters.

• Strategy centers on being the reinvention partner of choice, leveraging technology, data, and AI to deliver 360° value for clients, people, shareholders, partners, and communities.

• Fiscal 2024 saw record bookings ($81.2B), revenue growth to $64.9B, operating margin expansion to 14.8%, and $7.8B returned to shareholders.

• Investments included $6.6B in R&D, $1.2B in acquisitions, and $1.1B in employee learning and development.

Voting matters and shareholder proposals

• Shareholders will vote on the appointment of 11 director nominees, non-binding approval of executive compensation, ratification of KPMG as auditor, and several Irish law proposals (capital reduction, share issuance authority, pre-emption rights, and treasury share re-allotment).

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board refreshment includes two new nominees (Jennifer Nason and Masahiko Uotani); independent Lead Director succession from Gilles C. Pélisson to Arun Sarin.

• Board diversity: 45% women, 55% racially/ethnically diverse, average tenure 5.6 years.

• All committees are 100% independent; strong governance practices include annual elections, proxy access, no poison pill, and robust evaluation processes.

• Director overboarding policy and active shareholder engagement are in place.